Alpine Immune Sciences News Today

Battle twith microsoft and the battle with prime. Things were in a different place with layoffs and a big restructuring taking place with the distribution model at the company. If you look at where things are right now, even with some of the downward pressure on stocks across the board, you are looking at the market cap of 1. 9 trillion. The Company Making 575 billion in revenue and sitting on 70 billion of cash. The stock is up year to date and is now up 6 since andy jassy took over from jeff b...

Frazier Life Sciences Management L.P. lifted its holdings in Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) by 4.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,131,008 shares of the biotechnology company’s stock after buying an additional 145,251 shares during the quarter. Alpine […]

Capstone Investment Advisors LLC purchased a new position in shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 25,289 shares of the biotechnology company’s stock, valued at approximately $482,000. Other institutional investors also […]

Monashee Investment Management LLC purchased a new position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 74,792 shares of the biotechnology company’s stock, valued at approximately $1,426,000. A number of other institutional investors […]

Vertex Pharmaceuticals (VRTX), United Therapeutics (UTHR), and Novo Nordisk (NVO) are the top 3 biotech stocks to buy in May 2024.

Shares of the growing biotech company have doubled in three years.

VRTX earnings call for the period ending March 31, 2024.

By Paul Ziobro Vertex Pharmaceuticals posted double-digit sales growth in the first-quarter, topping Wall Street expectations, on continued growth of its drug that treats cystic fibrosis. ...

These great stocks are great picks for investors as spring winds down.